Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association.

Veysel Levent Karabas Ecem Onder Tokuc Figen Şermet

Published in: Turkish journal of ophthalmology (2022)

Bevacizumab is widely used as a first-line treatment for all indications of anti-VEGF use in the current reimbursement conditions, which preclude the right of ophthalmologists to treat according to their own preferences.

Keyphrases

age related macular degeneration
vascular endothelial growth factor
decision making
endothelial cells
diabetic retinopathy
cross sectional
optical coherence tomography
ultrasound guided
combination therapy
metastatic colorectal cancer